The US Food & Drug Administration (US FDA) has given final approval for Aurobindo Pharma Ltd. for the abbreviated new drug application (ANDA) for famciclovir tablets 125mg, 250mg and 500mg.
Famciclovir tablet is the generic version of Novartis Pharmaceuticals and is indicated for the treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients and also for suppression of recurrent genital herpes in immunocompetent patients.
AdvertisementThe Aurobindo Pharma Ltd. now has a total of 132 ANDA approvals from US FDA.
P Exposure To Pesticides Alters Semen Quality In Young Men Infrequent Sex Increases the Risk of Heart Attack M
You May Also Like